Vaxcyte, Inc. financial data

Symbol
PCVX on Nasdaq
Location
San Carlos, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 24 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1039% % -36%
Debt-to-equity 8.5% % 64%
Return On Equity -26% % -49%
Return On Assets -24% % -45%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 143,920,361 shares 12%
Common Stock, Shares, Outstanding 131,058,858 shares 4.9%
Entity Public Float $3,700,000,000 USD -49%
Common Stock, Value, Issued $134,000 USD 4.7%
Weighted Average Number of Shares Outstanding, Basic 136,089,506 shares 12%
Weighted Average Number of Shares Outstanding, Diluted 136,089,506 shares 12%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $794,306,000 USD 67%
General and Administrative Expense $129,369,000 USD 39%
Operating Income (Loss) $923,675,000 USD -62%
Nonoperating Income (Expense) $157,047,000 USD 49%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $766,628,000 USD -65%
Earnings Per Share, Basic -5.63 USD/shares -48%
Earnings Per Share, Diluted -5.63 USD/shares -48%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $173,959,000 USD -55%
Other Assets, Current $1,594,000 USD -22%
Assets, Current $1,627,361,000 USD -9%
Property, Plant and Equipment, Net $257,370,000 USD 30%
Operating Lease, Right-of-Use Asset $116,009,000 USD 61%
Other Assets, Noncurrent $118,847,000 USD 85%
Assets $3,002,717,000 USD -14%
Accounts Payable, Current $70,904,000 USD 46%
Employee-related Liabilities, Current $23,000,000 USD 12%
Accrued Liabilities, Current $31,068,000 USD 6.7%
Liabilities, Current $205,750,000 USD 47%
Operating Lease, Liability, Noncurrent $111,357,000 USD 71%
Other Liabilities, Noncurrent $100,000 USD 0%
Liabilities $317,207,000 USD 54%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,587,000 USD
Retained Earnings (Accumulated Deficit) $2,154,947,000 USD -55%
Stockholders' Equity Attributable to Parent $2,685,510,000 USD -19%
Liabilities and Equity $3,002,717,000 USD -14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $166,274,000 USD -4.5%
Net Cash Provided by (Used in) Financing Activities $759,000 USD -100%
Net Cash Provided by (Used in) Investing Activities $123,317,000 USD
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 131,058,858 shares 4.9%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $41,026,000 USD -119%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $175,425,000 USD -55%
Deferred Tax Assets, Valuation Allowance $645,313,000 USD 45%
Deferred Tax Assets, Gross $688,561,000 USD 47%
Operating Lease, Liability $117,581,000 USD 65%
Payments to Acquire Property, Plant, and Equipment $5,424,000 USD -4.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $761,168,000 USD -63%
Lessee, Operating Lease, Liability, to be Paid $164,290,000 USD 64%
Property, Plant and Equipment, Gross $290,140,000 USD 35%
Operating Lease, Liability, Current $6,124,000 USD 4%
Lessee, Operating Lease, Liability, to be Paid, Year Two $15,788,000 USD 64%
Lessee, Operating Lease, Liability, to be Paid, Year One $12,104,000 USD 11%
Operating Lease, Weighted Average Discount Rate, Percent 0.072 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $46,709,000 USD 61%
Lessee, Operating Lease, Liability, to be Paid, Year Three $17,339,000 USD 101%
Deferred Tax Assets, Operating Loss Carryforwards $336,106,000 USD 72%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $14,036,000 USD 47%
Lessee, Operating Lease, Liability, to be Paid, Year Four $17,859,000 USD 90%
Operating Lease, Payments $12,729,000 USD 11%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $2,956,000 USD 196%
Deferred Tax Assets, Net of Valuation Allowance $43,248,000 USD 97%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%